We randomly allocated children @-@ years of age to receive trivalent inactivated influenza vaccine ( TIV ) or placebo from September @ through January @ , and then conducted follow-up for @ years including regular collection of sera , symptom diaries , and collection of nose and throat swabs during illness episodes in participants or their household members .